Previous 10 | Next 10 |
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended...
MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governa...
2024-03-20 11:04:37 ET More on R1 RCM Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment R1 RCM Inc. (RCM) Q4 2023 Earnings Call Transcript R1 RCM Inc. 2023 Q4 - Results - Earnings Call Presentation R1 RCM demands that New Mounta...
2024-03-19 09:31:57 ET More on R1 RCM Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment R1 RCM Inc. (RCM) Q4 2023 Earnings Call Transcript R1 RCM Inc. 2023 Q4 - Results - Earnings Call Presentation R1 RCM forms special committee to e...
2024-03-12 15:08:43 ET More on S&P 500 Index: The Great Paradox Of The U.S. Market Stocks Rally As Implied Volatility Drops Following Hot CPI Report February CPI: Back-To-Back Hot Inflation May Extend The Fed's Pause Nasdaq, S&P, Dow climb as latest C...
2024-03-11 08:24:16 ET More on R1 RCM Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment R1 RCM Inc. (RCM) Q4 2023 Earnings Call Transcript R1 RCM Inc. 2023 Q4 - Results - Earnings Call Presentation R1 RCM slips after cut to hold at T...
MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation ...
2024-03-05 09:51:20 ET More on R1 RCM Voss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative Sentiment R1 RCM Inc. (RCM) Q4 2023 Earnings Call Transcript R1 RCM Inc. 2023 Q4 - Results - Earnings Call Presentation R1 RCM dips as Citi downgrades to n...
2024-02-28 07:15:02 ET Leerink Partners analyst issues UNDERPERFORM recommendation for RCM on February 28, 2024 07:00AM ET. The previous analyst recommendation was Underperform. RCM was trading at $14.58 at issue of the analyst recommendation. The overall analyst consens...
MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...